Serotype distribution of Streptococcus pneumonia in children with invasive disease in Turkey: 2015-2018

References

• World Health Organization. Pneumococcal diseases (updated 2015 Nov 16). https://www.who.int/biologicals/vaccines/pneumococcal/en/
   Google Scholar
• Pletz MW, Maus U, Krug N, Welte T, Lode H. Pneumococcal vaccines: mechanism of action, impact on epidemiology and adaption of the species. Int J Antimicrob Agents. 2008;32:199–206. doi:10.1016/j.ijantimicag.2008.01.021.
   PubMed Web of Science ®Google Scholar
• Feikin DR, Klugman KP. Historical changes in pneumococcal serogroup distribution: implications for the era of pneumococcal conjugate vaccines. Clin Infect Dis. 2002;35:547–55. doi:10.1086/341896.
   PubMed Web of Science ®Google Scholar
• Weinberger DM, Malley R, Lipsitch M. Serotype replacement in disease after pneumococcal vaccination. Lancet. 2011;378:1962–73. doi:10.1016/S0140-6736(10)62225-8.
   PubMed Web of Science ®Google Scholar
• Ozsurekci Y, Ceyhan M, Gurler N, Öksüz L, Aydemir S, Özkan S, Yüksekkaya S, Emiroğlu MK, Gültekin M, Yaman A, et al. Serotype distribution of Streptococcus pneumoniae in children with invasive diseases in Turkey: 2008–2014. Hum Vaccin Immunother. 2016;12:308–13. doi:10.1080/21645515.2015.1078952.
   PubMed Web of Science ®Google Scholar
• Wantuch PL, Avci FY. Current status and future directions of invasive pneumococcal diseases and prophylactic approaches to control them. Hum Vaccin Immunother. 2018;14:2303–09. doi:10.1080/21645515.2018.1470726.
   PubMed Web of Science ®Google Scholar
• Westerink MA, Schroeder HW, Nahm MH. Immune Responses to pneumococcal vaccines in children and adults: rationale for age-specific vaccination. Aging Dis. 2012;3:51–67.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Pneumococcal conjugate vaccine for childhood immunization – WHO position paper. Weekly epidemiological report. Weekly Epidemiological Rec. 2007;82:93–104.
   PubMedGoogle Scholar
• Weil-Olivier C, van der Linden M, de Schutter I, Dagan R, Mantovani L. Prevention of pneumococcal diseases in the post-seven valent vaccine era: a European perspective. BMC Infect Dis. 2012;12:207. doi:10.1186/1471-2334-12-207.
   PubMed Web of Science ®Google Scholar
• Johnson HL, Deloria-Knoll M, Levine OS, Stoszek SK, Freimanis Hance L, Reithinger R, Muenz LR, O’Brien KL. Systematic evaluation of serotypes causing invasive pneumococcal disease among children under five: the pneumococcal global serotype project. PLoS Med. 2010;7:e1000348. doi:10.1371/journal.pmed.1000348.
   PubMed Web of Science ®Google Scholar
• Ceyhan M, Ozsurekci Y, Gurler N, Ozkan S, Sensoy G, Belet N, Hacimustafaoglu M, Celebi S, Keser M, Dinleyici EC, et al. Serotype distribution of Streptococcus pneumoniae causing parapneumonic empyema in Turkey. Clin Vaccine Immunol. 2013;20:972–76. doi:10.1128/CVI.00765-12.
   PubMed Web of Science ®Google Scholar
• Ceyhan M, Gurler N, Ozsurekci Y, Keser M, Aycan AE, Gurbuz V, Salman N, Camcioglu Y, Dinleyici EC, Ozkan S, et al. Meningitis caused by Neisseria meningitidis, haemophilus influenzae type B and streptococcus pneumoniae during 2005-2012 in Turkey: A multicenter prospective surveillance study. Hum Vaccin Immunother. 2014;10:2706–12. doi:10.4161/hv.29678.
   PubMed Web of Science ®Google Scholar
• Yalcin I, Gurler N, Alhan E, Yaman A, Turgut M, Celik U, Akcakaya N, Camcioglu Y, Diren S, Yildirim B. Serotype distribution and antibiotic susceptibility of invasive Streptococcus pneumoniae disease isolates from children in Turkey, 2001-2004. Eur J Pediatr. 2006;165:654–57. doi:10.1007/s00431-006-0128-x.
   PubMed Web of Science ®Google Scholar
• Performance standards for antimicrobial disk susceptibility tests; approved standard-eleventh edition. Wayne (PA): Clinical and Laboratory Standards Institute; 2016. p. 9–10. [accessed Jan 31] http://www.antimicrobianos.com.ar/ATB/wp-content/uploads/2012/11/01-CLSI-M02-A11-2012.pdf
   Google Scholar
• Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing—twenty-fifth informational supplement. Wayne (PA): Clinical and Laboratory Standards Institute; 2015.
   Google Scholar
• Ceyhan M, Gurler N, Yaman A, Ozturk C, Oksuz L, Ozkan S, Keser M, Salman N, Alhan E, Esel D, et al. Serotypes of Streptococcus pneumoniae isolates from children with invasive pneumococcal disease in Turkey: baseline evaluation of the introduction of the pneumococcal conjugate vaccine nationwide. Clin Vaccine Immunol. 2011;18:1028–30. doi:10.1128/CVI.00526-10.
   PubMedGoogle Scholar
• Isaacman DJ, McIntosh ED, Reinert RR. Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines. Int J Infect Dis. 2010;14:e197–209. doi:10.1016/j.ijid.2009.05.010.
   PubMed Web of Science ®Google Scholar
• Htar MTH, Christopoulou D, Schmitt HJ. Pneumococcal serotype evolution in Western Europe. BMC Infect Dis. 2015;15:419. doi:10.1186/s12879-015-1147-x.
   PubMed Web of Science ®Google Scholar
• Turkey Ministery of Health. [ accessed 2019 Dec 20]. https://www.saglik.gov.tr/tr,11588/istatistik-yilliklari.html
   Google Scholar
• Antachopoulos C, Tsolia MN, Tzanakaki G, Xirogianni A, Dedousi O, Markou G, Zografou SM, Eliades A, Kirvassilis F, Kesanopoulos K, et al. Parapneumonic pleural effusions caused by Streptococcus pneumoniae serotype 3 in children immunized with 13-valent conjugated pneumococcal vaccine. Pediatr Infect Dis J. 2014;33:81–83. doi:10.1097/INF.0000000000000041.
   PubMed Web of Science ®Google Scholar
• Madhi F, Godot C, Bidet P, Bahuaud M, Epaud R, Cohen R. Serotype 3 pneumococcal pleural empyema in an immunocompetent child after 13-valent pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2014;33:545–46. doi:10.1097/INF.0000000000000252.
   PubMed Web of Science ®Google Scholar
• Angoulvant F, Levy C, Grimprel E, Varon E, Lorrot M, Biscardi S, Minodier P, Dommergues MA, Hees L, Gillet Y, et al. Early impact of 13-valent pneumococcal conjugate vaccine on community acquired pneumonia in children. Clin Infect Dis. 2014;58:918–24. doi:10.1093/cid/ciu006.
   PubMed Web of Science ®Google Scholar
• Pírez MC, Algorta G, Chamorro F, Romeo C, Varela A, Cedres A, Giachetto G, Montano A. Changes in hospitalizations for pneumonia after universal vaccination with pneumococcal conjugate vaccines 7/13 valent and haemophilus influenzae type b conjugate vaccine in a pediatric referral hospital in uruguay. Pediatr Infect Dis J. 2014;33:753–59. doi:10.1097/INF.0000000000000294.
   PubMed Web of Science ®Google Scholar
• Godot C, Levy C, Varon E, Picard C, Madhi F, Cohen R. Pneumococcal meningitis vaccine breakthroughs and failures after routine 7-valent and 13-valent pneumococcal conjugate vaccination in children in France. Pediatr Infect Dis J. 2015;34:e260–e263. doi:10.1097/INF.0000000000000818.
   PubMed Web of Science ®Google Scholar
• Moraga-Llop F, Garcia-Garcia JJ, Díaz- Conradi A, Ciruela P, Martinez-Osorio J, Gonzalez-Peris S, Hernandez S, de Sevilla MF, Uriona S, Izquierdo C, et al. Vaccine failures in patients properly vaccinated with 13- valent pneumococcal conjugate vaccine in Catalonia, a region with low vaccination coverage. Pediatr Infect Dis J. 2016;35:460–63. doi:10.1097/INF.0000000000001041.
   PubMed Web of Science ®Google Scholar
• Sütcü M, Aktürk H, Karagozlü F, Somer A, Guler N, Salman N. Empyema due to streptococcus pneumoniae serotype 9V in a child immunized with 13-valent conjugated pneumococcal vaccine. Balkan Med J. 2017;34:74–77. doi:10.4274/balkanmedj.2015.0937.
   PubMed Web of Science ®Google Scholar
• Diawara I, Zerouali K, Elmdaghri N, Abid A. A case report of parapneumonic pleural effusion caused by Streptococcus pneumoniae serotype 19A in a child immunized with 13-valent conjugate pneumococcal vaccine. BMC Pediatr. 2017;17:114. doi:10.1186/s12887-017-0872-2.
   PubMed Web of Science ®Google Scholar
• Tanır Basaranoglu S, Karadag Oncel E, Aykac K, Ozsurekci Y, Cengiz AB, Kara A, Ceyhan M. Invasive pneumococcal disease: from a tertiary care hospital in the post-vaccine era. Hum Vaccin Immunother. 2017 Apr;3(13):962–64. doi:10.1080/21645515.2016.1256519.
   Google Scholar
• Oligbu G, Hsia Y, Folgori L, Collins S, Ladhani S. Pneumococcal conjugate vaccine failure in children: A systematic review of the literature. Vaccine. 2016;34:6126–32. doi:10.1016/j.vaccine.2016.10.050.
   PubMed Web of Science ®Google Scholar
• Kaplan SL, Barson WJ, Lin PL, Romero JR, Bradley JS, Tan TQ, Pannaraj PS, Givner LB, Hulten KG. Invasive Pneumococcal Disease in Children’s Hospitals: 2014-2017. Pediatrics. 2019;144:e20190567. doi:10.1542/peds.2019-0567.
   PubMed Web of Science ®Google Scholar
• Balsells E, Guillot L, Nair H, Kyaw MH. Serotype distribution of Streptococcus pneumoniae causing invasive disease in children in the post-PCV era: A systematic review and meta-analysis. PLoS One. 2017;12:e0177113. doi:10.1371/journal.pone.0177113.
   PubMed Web of Science ®Google Scholar
• Jaiswal N, Singh M, Das RR, Jindal I, Agarwal A, Thumburu KK, Kumar A, Chauhan A. Distribution of serotypes, vaccine coverage, and antimicrobial susceptibility pattern of Streptococcus pneumoniae in children living in SAARC countries: a systematic review. PLoS One. 2014;9:e108617. doi:10.1371/journal.pone.0108617.
   PubMed Web of Science ®Google Scholar
• Gregory JT. The Changing Epidemiology of Streptococcus pneumoniae Serotype 19A Clonal Complexes. J Infect Dis. 2011;203:1345–47. doi:10.1093/infdis/jir056.
   PubMed Web of Science ®Google Scholar
• Steens A, Bergsaker MA, Aaberge IS, Rønning K, Vestrheim DF. Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway. Vaccine. 2013;31:6232–38. doi:10.1016/j.vaccine.2013.10.032.
   PubMed Web of Science ®Google Scholar
• Greenberg D, Hoover PA, Vesikari T, Peltier C, Hurley DC, McFetridge RD, Dallas M, Hartzel J, Marchese RD, Coller BG, et al. Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV15) in healthy infants. Vaccine. 2018;36:6883–91. doi:10.1016/j.vaccine.2018.02.113.
   PubMed Web of Science ®Google Scholar
• Thompson A, Lamberth E, Severs J, Scully I, Tarabar S, Ginis J, Jansen KU, Gruber WC, Scott DA, Watson W. Phase 1 trial of a 20-valent pneumococcal conjugate vaccine in healthy adults. Vaccine. 2019;37:6201–07. doi:10.1016/j.vaccine.2019.08.048.
   PubMed Web of Science ®Google Scholar
• Improving global health by preventing pneumococcal disease. Report from the All-Party Parliamentary Group on Pneumococcal Disease Prevention in the Developing World. www.gavi.org/Library/Documents/AMC/All-Party-Parlimentary-Group-on-Pneumococcal-Disease-Report
   Google Scholar
• Liñares J, Ardanuy C, Pallares R, Fenoll A. Changes in antimicrobial resistance, serotypes and genotypes in Streptococcus pneumoniae over a 30-year period. Clin Microbiol Infect. 2010;16:402–10. doi:10.1111/j.1469-0691.2010.03182.x.
   PubMed Web of Science ®Google Scholar
• Dagan R, Klugman KP. Impact of conjugate pneumococcal vaccines on antibiotic resistance. Lancet Infect Dis. 2008;8:785–95. doi:10.1016/S1473-3099(08)70281-0.
   PubMed Web of Science ®Google Scholar